Thymic atrophy and regrowth in response to chemotherapy: CT evaluation

Twenty-nine consecutive patients 2-35 years old underwent serial thoracic CT evaluations for metastatic disease. Thymic volumes were determined for each patient during cycles of chemotherapy and were compared with the patient's clinical status. This group included patients with Hodgkin's disease (13 patients), osteogenic sarcoma (five), testicular neoplasm (four), Wilms' tumor (three), rhabdomyosarcoma (two), malignant fibrous histiocytoma (one), and Ewing's sarcoma (one). Seven patients with mediastinal lymphoma had tumor involvement of the thymus and therefore were excluded. The 22 remaining patients showed cyclic thymic volume changes in response to chemotherapy or its discontinuance. During the first course of chemotherapy the thymic volume decreased by an average of 43% in 20 of 22 patients. Between the first and second course, regrowth was observed in all 20 of these patients. Among the six patients who received a second course of therapy, an average volume decrease of 36% was observed during the second course with regrowth again occurring during recovery from chemotherapy. Thymic rebound (regrowth 50% greater than baseline volume) occurred in five patients, three of whom were in clinical remission. The thymus appears to atrophy during the administration of chemotherapy and regrow during the recovery phase of chemotherapy in 90% of the patients studied. Thymic hyperplasia or rebound is a relatively common phenomenon occurring in 25% of patients. The size of the thymus appears to be extremely sensitive to chemotherapy.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Nishino, S. K. Ashiku, O. N. Kocher, R. L. Thurer, P. M. Boiselle, and H. Hatabu The thymus: a comprehensive review. RadioGraphics, March 1, 2006; 26(2): 335 - 348. [Abstract] [Full Text] [PDF]

				C. Wittram, A. J. Fischman, E. Mark, J. Ko, and J.-A. O. Shepard Thymic Enlargement and FDG Uptake in Three Patients: CT and FDG Positron Emission Tomography Correlated with Pathology Am. J. Roentgenol., February 1, 2003; 180(2): 519 - 522. [Abstract] [Full Text] [PDF]

				J. M. Franco, A. Rubio, M. Martinez-Moya, M. Leal, E. Merchante, A. Sanchez-Quijano, and E. Lissen T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy Blood, May 15, 2002; 99(10): 3702 - 3706. [Abstract] [Full Text] [PDF]

				I. Brink, M. J. Reinhardt, S. Hoegerle, C. Altehoefer, E. Moser, and E. U. Nitzsche Increased Metabolic Activity in the Thymus Gland Studied with 18F-FDG PET: Age Dependency and Frequency After Chemotherapy J. Nucl. Med., April 1, 2001; 42(4): 591 - 595. [Abstract] [Full Text]

				C. L. Mackall, T. A. Fleisher, M. R. Brown, M. P. Andrich, C. C. Chen, I. M. Feuerstein, I. T. Magrath, L. H. Wexler, D. S. Dimitrov, and R. E. Gress Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy Blood, May 15, 1997; 89(10): 3700 - 3707. [Abstract] [Full Text] [PDF]

				C. L. Mackall, T. A. Fleisher, M. R. Brown, M. P. Andrich, C. C. Chen, I. M. Feuerstein, M. E. Horowitz, I. T. Magrath, A. T. Shad, S. M. Steinberg, et al. Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy N. Engl. J. Med., January 19, 1995; 332(3): 143 - 149. [Abstract] [Full Text] [PDF]